Rüdiger Autschbach

Rüdiger Autschbach

Auto-generated profile, based on publicly available information

Rüdiger Autschbach

Department of Thoracic and Cardio-Vascular Surgery, University Hospital RWTH Aachen, Aachen, Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Ultrasonography
Verified
Journal Article
Open access
PDF file
SFSebastian Johannes Fritsch
Sebastian Johannes Fritsch
NHNima Hatam
Nima Hatam
AGAndreas Goetzenich
Andreas Goetzenich
GMGernot Marx
Gernot Marx
RARüdiger Autschbach
Rüdiger Autschbach
CBChristian Simon Bruells
Christian Simon Bruells
A reliable method of measuring diaphragmatic function at the bedside is still lacking. Widely used two-dimensional (2D) ultrasonographic measurements, such as diaphragm excursion, diaphragm thickness, and fractional thickening (FT) have failed to show clear correlations with diaphragmatic function. A reason for this is that 2D ultrasonographic measurements, like FT, are merely able to measure the deformation of muscular diaphragmatic tissue in the transverse direction, while longitudinal measurements in the direction of contracting muscle fibres are not possible. Speckle tracking ultrasonography, which is widely used in cardiac imaging, overcomes this disadvantage and allows observations of movement in the direction of the contracting muscle fibres, approximating muscle deformation and the deformation velocity. Several studies have evaluated speckle tracking as a promising method to assess diaphragm contractility in healthy subjects. This technical note demonstrates the feasibility of speckle tracking ultrasonography of the diaphragm in a group of 20 patients after an aortocoronary bypass graft procedure. The results presented herein suggest that speckle tracking ultrasonography is able to depict alterations in diaphragmatic function after surgery better than 2D ultrasonographic measurements.

1 January 2021
Verified
Conference Paper
Closed access
RZRashad Zayat
Rashad Zayat
OAO. Allham
O. Allham
ARAdrian Rotaru
Adrian Rotaru
ADA. H. Diab
A. H. Diab
KHKatharina Huenges
Katharina Huenges
AHA. Haneya
A. Haneya
Objectives: Hemocompatibility-related adverse events (HRAEs) remain the Achilles heel of left ventricular assist device (LVAD) treatment. Previous study showed Promising results of the HeartMate 3 (HM3) device with lower HRAEs than with the HeartMate II (HMII) LVAD. This study aims to compare HRAEs and long-term outcomes between HMII, HeartWare (HVAD) and HM3 in a real-life cohort. Methods: We retrospectively analyzed all patients who received LVAD implantation between January 2014 and October 2019 in three mid-volume German centers. Long-term outcomes and HRAEs according to MONEMTUM3 trial's definitions were compared between HM3, HMII, and HVAD patients. We utilized competing risk regression to analyze survival free of HRAEs. Result: A total of 327 patients, 84% male with a median age of 65 years (HM3 [n = 73], HMII [n = 142], HVAD [n = 112]) contributed to a total person-time at risk of 7,793 months. Median follow-up was 22 months (IQR: 37). Intention to treat as destination therapy did not differ among HM3, HMII, and HVAD patients (53 vs. 47 vs. 51%, p = 0.627, respectively). Distribution of INTERMACS levels I and II was similar between HM3, HMII, and HVAD patients (25 vs. 30 vs. 33%, p = 0.305, respectively). HVAD and HMII patients had significantly decreased HRAEs free survival compared with HM3 (sub-hazard ratio [SHR]: 2.89 [95% CI: 1.52–5.49], p = 0.001 and SHR 3.07 [95% CI: 1.63–5.78], p = 0.001, respectively). Conclusion: HeartMate 3 showed the lowest HCS with significantly lower HRAEs compared with HVAD and HMII. HVAD patients had the highest pump thrombosis incidence. Distribution of bleeding events was similar between all three devices. HVAD and HMII patients had a clear increased hazard ratio for mortality because of HRAEs compared with HM3 patients. Publication Date: 19 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany